Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Lazzarin

Showing results (111-120 of 288) with videos related to

Pageof 29
Sort By:
AIDS (London, England)|October 23, 2003
Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysisSilvana Tasca, Giuseppe Tambussi, Silvia Nozza, et al.
AIDS (London, England)|March 15, 2005
Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patientsOmbretta Turriziani, Ornella Butera, Nicola Gianotti, et al.
AIDS (London, England)|January 24, 2009
Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapiesFilippo Canducci, Michela Sampaolo, Maria Chiara Marinozzi, et al.
Journal of Clinical Immunology|April 8, 2006
Immunological basis for IgE hyper-production in enfuvirtide-treated HIV- positive patientsSamuele E Burastero, Clara Paolucci, Daniela Breda, et al.
AIDS (London, England)|October 4, 2008
The therapeutic phase I trial of the recombinant native HIV-1 Tat proteinBarbara Ensoli, Valeria Fiorelli, Fabrizio Ensoli, et al.
Pharmacogenetics and Genomics|April 9, 2010
An epidemiologic study to determine the prevalence of the HLA-B*5701 allele among HIV-positive patients in EuropeChloe Orkin, Jianmin Wang, Colm Bergin, et al.
The New Microbiologica|May 29, 2023
No need to modify treatment within the first month after rapid start of a tailored antiretroviral therapy: the TWODAY StudyNicola Gianotti, Laura Galli, Michela Sampaolo, et al.
Antiviral Therapy|June 9, 2006
Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapyGiovanni Sitia, Anna De Bona, Sabrina Bagaglio, et al.
European Journal of Epidemiology|June 23, 2012
Risk of type 2 diabetes among HIV-infected and healthy subjects in ItalyLaura Galli, Stefania Salpietro, Gabriele Pellicciotta, et al.
The Journal of Antimicrobial Chemotherapy|October 12, 2011
Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mLNicola Gianotti, Laura Galli, Sara Racca, et al.
Pageof 29

Showing results (111-120 of 288) with videos related to

Sort By:
Pageof 29
AIDS (London, England)|October 23, 2003
Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysisSilvana Tasca, Giuseppe Tambussi, Silvia Nozza, et al.
AIDS (London, England)|March 15, 2005
Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patientsOmbretta Turriziani, Ornella Butera, Nicola Gianotti, et al.
AIDS (London, England)|January 24, 2009
Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapiesFilippo Canducci, Michela Sampaolo, Maria Chiara Marinozzi, et al.
Journal of Clinical Immunology|April 8, 2006
Immunological basis for IgE hyper-production in enfuvirtide-treated HIV- positive patientsSamuele E Burastero, Clara Paolucci, Daniela Breda, et al.
AIDS (London, England)|October 4, 2008
The therapeutic phase I trial of the recombinant native HIV-1 Tat proteinBarbara Ensoli, Valeria Fiorelli, Fabrizio Ensoli, et al.
Pharmacogenetics and Genomics|April 9, 2010
An epidemiologic study to determine the prevalence of the HLA-B*5701 allele among HIV-positive patients in EuropeChloe Orkin, Jianmin Wang, Colm Bergin, et al.
The New Microbiologica|May 29, 2023
No need to modify treatment within the first month after rapid start of a tailored antiretroviral therapy: the TWODAY StudyNicola Gianotti, Laura Galli, Michela Sampaolo, et al.
Antiviral Therapy|June 9, 2006
Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapyGiovanni Sitia, Anna De Bona, Sabrina Bagaglio, et al.
European Journal of Epidemiology|June 23, 2012
Risk of type 2 diabetes among HIV-infected and healthy subjects in ItalyLaura Galli, Stefania Salpietro, Gabriele Pellicciotta, et al.
The Journal of Antimicrobial Chemotherapy|October 12, 2011
Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mLNicola Gianotti, Laura Galli, Sara Racca, et al.
Pageof 29